AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19644361 — intervention group
Group type: EXPERIMENTAL
Intervention: NT 201 (median, 320 U)
Number of subjects: 148
Study 19644361 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study 16160652 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain perfusion SPECT with 99mTc-ECD
Number of subjects: 16
Study 12298188 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril and captopril
Number of subjects: 0
Study 12298188 — intervention group
Group type: COMPARATOR
Intervention: Control group (normotensive persons)
Number of subjects: 0
Study 12298188 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated hypertensive subjects)
Number of subjects: 0
Study 12298188 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (including enalapril and captopril)
Number of subjects: 0
Study 10091877 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifater (combined formulation of isoniazid, rifampicin, and pyrazinamide)
Number of subjects: 310
Study 10091877 — intervention group
Group type: COMPARATOR
Intervention: Separate drugs (isoniazid, rifampicin, and pyrazinamide)
Number of subjects: 310
Study 7500544 — intervention group
Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA) 1.8 g/day, n = 12
Number of subjects: 22
Study 7500544 — intervention group
Group type: COMPARATOR
Intervention: Control group (no EPA treatment), n = 10
Number of subjects: 22
Study 2264174 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 (PGE2) vaginal tablets
Number of subjects: 88
Study 2264174 — intervention group
Group type: COMPARATOR
Intervention: Intravenous oxytocin
Number of subjects: 88
Study 7386409 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 g of cream fat
Number of subjects: 11
Study 7386409 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 g of saffola oil
Number of subjects: 11
Study 7386409 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric nonfat cornstarch control meal
Number of subjects: 11
Study 30482392 — intervention group
Group type: EXPERIMENTAL
Intervention: Apremilast, 30 mg twice daily
Number of subjects: 20
Study 30482392 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 28057030 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (0.5 mmol/kg loading dose for 1 hour, followed by 0.15 mmol/kg/h infusion for 23 hours)
Number of subjects: 70
Study 28057030 — intervention group
Group type: COMPARATOR
Intervention: Sodium chloride (control)
Number of subjects: 70
Study 25646324 — intervention group
Group type: EXPERIMENTAL
Intervention: High whey protein-, leucine-, and vitamin D-enriched supplement (150 kcal, 21 g protein; 10×/wk)
Number of subjects: 80
Study 25646324 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric control
Number of subjects: 80
Study 25646324 — intervention group
Group type: EXPERIMENTAL
Intervention: High whey protein-, leucine-, and vitamin D-enriched supplement
Number of subjects: 80
Study 22540676 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate functionally loaded implants (test implants)
Number of subjects: 13
Study 22540676 — intervention group
Group type: COMPARATOR
Intervention: Non-loaded implants (control implants)
Number of subjects: 13
Study 21359615 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% triamcinolone acetonide paste (0.5 mg)
Number of subjects: 143
Study 21359615 — intervention group
Group type: COMPARATOR
Intervention: 0.1% chlorhexidine gluconate jelly
Number of subjects: 143
Study 19302265 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide at doses >=0.5 mg
Number of subjects: 18
Study 19302265 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide at doses <0.5 mg
Number of subjects: 18
Study 16647307 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination B vaccine
Number of subjects: 0
Study 15519082 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior capsule polishing
Number of subjects: 52
Study 15519082 — intervention group
Group type: COMPARATOR
Intervention: Anterior capsule polishing (SI-40 IOL)
Number of subjects: 52
Study 15519082 — intervention group
Group type: COMPARATOR
Intervention: Anterior capsule polishing (Silens6 IOL)
Number of subjects: 52
Study 11485707 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone management
Number of subjects: 72
Study 11485707 — intervention group
Group type: COMPARATOR
Intervention: Usual office-based care
Number of subjects: 72
Study 9684213 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational group approach to self-management (16 group sessions)
Number of subjects: 88
Study 9684213 — intervention group
Group type: COMPARATOR
Intervention: Control group (25 individuals)
Number of subjects: 88
Study 8111941 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium 0.07 mg.kg‐1
Number of subjects: 52
Study 8111941 — intervention group
Group type: COMPARATOR
Intervention: Pancuronium 0.015 mg.kg‐1
Number of subjects: 52
Study 2460831 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter reuse during electrophysiologic studies
Number of subjects: 12
Study 2460831 — intervention group
Group type: COMPARATOR
Intervention: Single use of pacing catheters
Number of subjects: 12
Study 29178126 — intervention group
Group type: EXPERIMENTAL
Intervention: McGrath VL
Number of subjects: 84
Study 29178126 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 84
Study 26843140 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation of 1200 IU d−1 for 11 months
Number of subjects: 132
Study 26424831 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal antiretrovirals
Number of subjects: 2369
Study 26424831 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant nevirapine
Number of subjects: 2369
Study 26424831 — intervention group
Group type: COMPARATOR
Intervention: Neither intervention
Number of subjects: 2369
Study 24622227 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention group
Number of subjects: 117
Study 24622227 — intervention group
Group type: COMPARATOR
Intervention: Health-education group
Number of subjects: 117
Study 21409424 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam combined with fentanyl (50-100 mg)
Number of subjects: 480
Study 21409424 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam combined with propofol (0.5-2.5 mg/kg)
Number of subjects: 480
Study 21409424 — intervention group
Group type: COMPARATOR
Intervention: Midazolam alone (1.0-2.0 mg)
Number of subjects: 480
Study 18182121 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine infusion
Number of subjects: 20
Study 18182121 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 20
Study 16357087 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal continuous positive airway pressure (CPAP) for 14 days
Number of subjects: 50
Study 16357087 — intervention group
Group type: COMPARATOR
Intervention: Placebo CPAP (administered at ineffective pressure)
Number of subjects: 50
Study 16357087 — intervention group
Group type: COMPARATOR
Intervention: Oxygen supplementation
Number of subjects: 50
Study 12571128 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body skin cooling (water‐perfused suits) at 0600 (AM) and 1600 (PM)
Number of subjects: 0
Study 12571128 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body skin cooling (water‐perfused suits) at 0600 (AM)
Number of subjects: 0
Study 12571128 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body skin cooling (water‐perfused suits) at 1600 (PM)
Number of subjects: 0
Study 12571128 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body skin cooling (water‐perfused suits)
Number of subjects: 0
Study 10487284 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandimmune cyclosporin A 2.5 mg/kg b.i.d.
Number of subjects: 10
Study 10487284 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoral cyclosporin A 2.5 mg/kg b.i.d.
Number of subjects: 10
Study 10487284 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited sampling model including concentration data at 2 and 12 h
Number of subjects: 10
Study 8522675 — intervention group
Group type: EXPERIMENTAL
Intervention: Flow-triggered (FT) system
Number of subjects: 10
Study 8522675 — intervention group
Group type: COMPARATOR
Intervention: Pressure-triggered (PT) system
Number of subjects: 10
Study 1682787 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-912 (2 mg)
Number of subjects: 10
Study 1682787 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 6786131 — intervention group
Group type: COMPARATOR
Intervention: Tidal volume of 6 ml/kg bodyweight
Number of subjects: 20
Study 6786131 — intervention group
Group type: EXPERIMENTAL
Intervention: Tidal volume of 15 ml/kg bodyweight
Number of subjects: 20
Study 31246068 — intervention group
Group type: COMPARATOR
Intervention: Contingency Management (CM)
Number of subjects: 59
Study 31246068 — intervention group
Group type: EXPERIMENTAL
Intervention: CM plus Working Memory Training (WMT)
Number of subjects: 59
Study 31246068 — intervention group
Group type: EXPERIMENTAL
Intervention: Working Memory Training (WMT)
Number of subjects: 59
Study 31246068 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher magnitude CM (Phase 2)
Number of subjects: 59
Study 27758729 — intervention group
Group type: EXPERIMENTAL
Intervention: Social problem-solving training (SPST) intervention
Number of subjects: 0
Study 27758729 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study 25868406 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic mesh‐augmented hiatoplasty with simple cardiophrenicopexy (LMAH‐C)
Number of subjects: 40
Study 25868406 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic mesh‐augmented hiatoplasty with fundoplication (LMAH‐F)
Number of subjects: 40
Study 25868406 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 40
Study 24289488 — intervention group
Group type: EXPERIMENTAL
Intervention: FACT-G
Number of subjects: 367
Study 24289488 — intervention group
Group type: EXPERIMENTAL
Intervention: CLAD model for EQ-5D
Number of subjects: 367
Study 24289488 — intervention group
Group type: EXPERIMENTAL
Intervention: GLM model for SF-6D
Number of subjects: 367
Study 21473827 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP levels of 10 cm H(2)O and 14 cm H(2)O in poor cardiac function group (n=19)
Number of subjects: 36
Study 21473827 — intervention group
Group type: COMPARATOR
Intervention: PEEP levels of 0 cm H(2)O in poor cardiac function group (n=19)
Number of subjects: 36
Study 21473827 — intervention group
Group type: COMPARATOR
Intervention: PEEP levels of 0 cm H(2)O in normal cardiac function group (n=17)
Number of subjects: 36
Study 19854329 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone therapy
Number of subjects: 16000
Study 19854329 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 16000
Study 17822972 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin (1.0%)
Number of subjects: 229
Study 17822972 — intervention group
Group type: COMPARATOR
Intervention: Fortified tobramycin/cephazolin
Number of subjects: 229
Study 17822972 — intervention group
Group type: COMPARATOR
Intervention: Ofloxacin (0.3%)
Number of subjects: 229
Study 14756739 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Abdominal Hysterectomy (TAH)
Number of subjects: 319
Study 14756739 — intervention group
Group type: EXPERIMENTAL
Intervention: Subtotal Abdominal Hysterectomy (SAH)
Number of subjects: 319
Study 14756739 — intervention group
Group type: COMPARATOR
Intervention: Total Abdominal Hysterectomy (TAH) and Subtotal Abdominal Hysterectomy (SAH)
Number of subjects: 319
Study 11477318 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit juice (GJ)
Number of subjects: 9
Study 11477318 — intervention group
Group type: COMPARATOR
Intervention: Losartan without grapefruit juice
Number of subjects: 9
Study 10690857 — intervention group
Group type: EXPERIMENTAL
Intervention: GH + LH-releasing hormone analog (LHRH-A)
Number of subjects: 21
Study 10690857 — intervention group
Group type: COMPARATOR
Intervention: GH alone
Number of subjects: 21
Study 10690857 — intervention group
Group type: EXPERIMENTAL
Intervention: GH + LHRH-A
Number of subjects: 21
Study 9351556 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular screening for prostate carcinoma
Number of subjects: 180000
Study 9351556 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 180000
Study 8475226 — intervention group
Group type: EXPERIMENTAL
Intervention: Delta sleep-inducing peptide (DSIP) 25 micrograms/kg bw IV over 30 min
Number of subjects: 8
Study 8475226 — intervention group
Group type: EXPERIMENTAL
Intervention: Arginine chlorhydrate 0.5 g/kg bw IV over 30 min
Number of subjects: 8
Study 8475226 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous DSIP plus arginine chlorhydrate administration
Number of subjects: 8
Study 8475226 — intervention group
Group type: COMPARATOR
Intervention: DSIP 25 micrograms/kg bw from 2130h to 2230h
Number of subjects: 8
Study 8475226 — intervention group
Group type: COMPARATOR
Intervention: Placebo IV infusion
Number of subjects: 8
Study 3310340 — intervention group
Group type: EXPERIMENTAL
Intervention: Corneal incision
Number of subjects: 0
Study 3310340 — intervention group
Group type: COMPARATOR
Intervention: Limbal incision
Number of subjects: 0
Study 3310340 — intervention group
Group type: EXPERIMENTAL
Intervention: Suture division
Number of subjects: 0
Study 29725806 — intervention group
Group type: EXPERIMENTAL
Intervention: PPC (polyacrylate‐polyalcohol copolymer)
Number of subjects: 44
Study 29725806 — intervention group
Group type: COMPARATOR
Intervention: Dx/HA (dextranomer‐hyaluronic acid copolymer)
Number of subjects: 44
Study 26559916 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally fluoroscopic approach (MFA) using EnSiteTMNavXTM navigation system
Number of subjects: 262
Study 26559916 — intervention group
Group type: COMPARATOR
Intervention: Conventional fluoroscopy‐guided ablation (ConvA)
Number of subjects: 262
Study 24888426 — intervention group
Group type: EXPERIMENTAL
Intervention: ECHOc guided self‐help (in addition to treatment as usual)
Number of subjects: 0
Study 24888426 — intervention group
Group type: EXPERIMENTAL
Intervention: ECHO self‐help only (in addition to treatment as usual)
Number of subjects: 0
Study 24888426 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual only
Number of subjects: 0
Study 22237062 — intervention group
Group type: EXPERIMENTAL
Intervention: Cow-milk products
Number of subjects: 232
Study 22237062 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruit and berry juices
Number of subjects: 232
Study 22237062 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh milk products and cow milk-based infant formulas
Number of subjects: 232
Study 22237062 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat from all milk products
Number of subjects: 232
Study 22237062 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein from fresh milk products
Number of subjects: 232
Study 19995493 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaceutical care shared between GPs and community pharmacists
Number of subjects: 551
Study 19995493 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 551
Study 19995493 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaceutical care
Number of subjects: 551
Study 18923223 — intervention group
Group type: EXPERIMENTAL
Intervention: Delton, a resin-based sealant
Number of subjects: 107
Study 18923223 — intervention group
Group type: COMPARATOR
Intervention: Fuji VII glass ionomer cement
Number of subjects: 107
Study 15815776 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukocyte-depleted blood cardioplegia (group A)
Number of subjects: 58
Study 15815776 — intervention group
Group type: COMPARATOR
Intervention: Standard blood cardioplegia (group B)
Number of subjects: 58
Study 12432162 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally appropriate smoking cessation intervention delivered in the smoker's home by trained lay health advisors (promotores) for three months
Number of subjects: 313
Study 12432162 — intervention group
Group type: COMPARATOR
Intervention: California Smoker's Helpline in Spanish
Number of subjects: 313
Study 10533840 — intervention group
Group type: EXPERIMENTAL
Intervention: Noradrenergic drug (S 12024‐2)
Number of subjects: 12
Study 10533840 — intervention group
Group type: COMPARATOR
Intervention: Control (no drug)
Number of subjects: 12
Study 8579490 — intervention group
Group type: EXPERIMENTAL
Intervention: Neo-adjuvant therapy with adriamycin and methotrexate
Number of subjects: 191
Study 8579490 — intervention group
Group type: EXPERIMENTAL
Intervention: Single transfusion of allogenic bone-marrow suspension
Number of subjects: 191
Study 1789401 — intervention group
Group type: EXPERIMENTAL
Intervention: Air-cleaning device equipped with a HEPA filter (2 months)
Number of subjects: 9
Study 1789401 — intervention group
Group type: COMPARATOR
Intervention: Control period (2 months without air-cleaner)
Number of subjects: 9
Study 29500828 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagery rescripting
Number of subjects: 107
Study 29500828 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive dissonance
Number of subjects: 107
Study 29500828 — intervention group
Group type: COMPARATOR
Intervention: Control (assessment-only)
Number of subjects: 107
Study 27130379 — intervention group
Group type: EXPERIMENTAL
Intervention: Chevron osteotomy
Number of subjects: 66
Study 27130379 — intervention group
Group type: EXPERIMENTAL
Intervention: Lindgren-Turan osteotomy
Number of subjects: 66
Study 24708578 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibody testing
Number of subjects: 1358
Study 24708578 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1358
Study 24708578 — intervention group
Group type: EXPERIMENTAL
Intervention: BAb titres
Number of subjects: 1358
Study 24708578 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial BAb-positive and NAb-positive status
Number of subjects: 1358
Study 22190137 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 g/day pectin
Number of subjects: 0
Study 22190137 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 g/day pectin
Number of subjects: 0
Study 22190137 — intervention group
Group type: COMPARATOR
Intervention: Control (cellulose)
Number of subjects: 0
Study 20211323 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary BMC therapy
Number of subjects: 42
Study 20211323 — intervention group
Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 42
Study 18410202 — intervention group
Group type: EXPERIMENTAL
Intervention: Morally elevating video
Number of subjects: 0
Study 18410202 — intervention group
Group type: COMPARATOR
Intervention: Comedy video (control)
Number of subjects: 0
Study 17221107 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (F) 60 mg/day
Number of subjects: 35
Study 17221107 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine (S) 15 mg/day
Number of subjects: 35
Study 17221107 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (M) 1,700 mg/day
Number of subjects: 35
Study 17221107 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 12798268 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental imagery of plantar flexion at 40% MVC
Number of subjects: 23
Study 12798268 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental imagery of plantar flexion at 60% MVC
Number of subjects: 23
Study 12798268 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental imagery of plantar flexion at 80% MVC
Number of subjects: 23
Study 12798268 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental imagery of plantar flexion at 100% MVC
Number of subjects: 23
Study 12798268 — intervention group
Group type: COMPARATOR
Intervention: Resting control trials
Number of subjects: 23
Study 10986547 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine 5 to 20 mg/d
Number of subjects: 115
Study 10986547 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115
Study 9001648 — intervention group
Group type: EXPERIMENTAL
Intervention: Taurine supplemented formula (FF + T)
Number of subjects: 3
Study 9001648 — intervention group
Group type: COMPARATOR
Intervention: Taurine non-supplemented formula (FF)
Number of subjects: 3
Study 9001648 — intervention group
Group type: COMPARATOR
Intervention: Breast-fed (BF)
Number of subjects: 3
Study 1600598 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg/m2 carboplatin plus 800 mg/m2 cyclophosphamide (level 1)
Number of subjects: 18
Study 1600598 — intervention group
Group type: EXPERIMENTAL
Intervention: 550 mg/m2 carboplatin plus 1100 mg/m2 cyclophosphamide (level 2)
Number of subjects: 18
Study 1600598 — intervention group
Group type: EXPERIMENTAL
Intervention: High doses of carboplatin and cyclophosphamide
Number of subjects: 18
Study 6152175 — intervention group
Group type: EXPERIMENTAL
Intervention: ICI 141,292 (Visacor) 50 mg
Number of subjects: 59
Study 6152175 — intervention group
Group type: EXPERIMENTAL
Intervention: ICI 141,292 (Visacor) 100 mg
Number of subjects: 59
Study 6152175 — intervention group
Group type: EXPERIMENTAL
Intervention: ICI 141,292 (Visacor) 200 mg
Number of subjects: 59
Study 6152175 — intervention group
Group type: EXPERIMENTAL
Intervention: ICI 141,292 (Visacor) 300 mg
Number of subjects: 59
Study 6152175 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 30646755 — intervention group
Group type: EXPERIMENTAL
Intervention: Device-supported titration
Number of subjects: 151
Study 30646755 — intervention group
Group type: COMPARATOR
Intervention: Routine titration
Number of subjects: 151
Study 30418521 — intervention group
Group type: EXPERIMENTAL
Intervention: WebRx (25-week/15-session web-delivered intervention)
Number of subjects: 61
Study 30418521 — intervention group
Group type: EXPERIMENTAL
Intervention: WebRx
Number of subjects: 61
Study 30418521 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 61
Study 27110817 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based comprehensive intervention including nutrition classes for children, mothers, and teachers, and physical activity classes for children.
Number of subjects: 258
Study 27110817 — intervention group
Group type: COMPARATOR
Intervention: Control group received physical activity (PA) classes only.
Number of subjects: 258
Study 24560128 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief alcohol intervention (BAI)
Number of subjects: 166
Study 23056633 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-labor cesarean section (CS)
Number of subjects: 78166
Study 23056633 — intervention group
Group type: COMPARATOR
Intervention: Trial of labor
Number of subjects: 78166